Oncology Clinical Trials Market
According to Intent Market Research, the Oncology Clinical Trials Market is expected to grow from USD 13.4 Billion in 2024-e at a CAGR of 11.9% to touch USD 26.4 Billion by 2030. The Oncology Clinical Trials Market is dominated by key players such as Pfizer Inc., Novartis AG, Merck & Co., Inc., AstraZeneca, Eli Lilly and Company, and Johnson & Johnson.